Sands to Resume Macau Casino Resort Construction
By wchung | 22 Jun, 2026
Sands Casino are seen in Macau Saturday, Oct.31, 2009. (AP Photo/Kin Cheung)
U.S. casino operator Las Vegas Sands Corp. plans to resume work in January on its multibillion-dollar gambling resorts in Macau after suspending construction last year amid a massive funding crunch, the company said Sunday.
This week Sands will seek to raise more than $3.3 billion from an initial public offering of shares in its casino businesses in the southern Chinese enclave, the world’s largest casino market.
About $500 million will be used to restart construction on the projects, executives said. The company plans to hire as many as 12,000 workers after 11,000 jobs were cut as a result of the suspension.
The projects, including casinos and Shangri-La and Sheraton hotels, were stalled last year as the company grappled with a cash shortage, brought on by the financial crisis and Sands’ massive debt load, that threatened its agreements with creditors.
Sands’ latest casino resorts are part of Chairman Sheldon Adelson’s quest to turn a section of Macau into a Chinese version of the Las Vegas Strip with a mix of gambling, conventions, shopping, entertainment and other draws.
“We expect that Macau will evolve into the same type of business model that the integrated resorts on the Las Vegas Strip have evolved into,” Adelson said in a video conference with reporters in Hong Kong.
Sands’ new shares are expected to begin trading on the Hong Kong Stock Exchange on Nov. 30, with the share price to be determined Nov. 21, according to the IPO’s terms.
It will mark the second Hong Kong IPO from an American casino operator. Shares in the Macau resorts of billionaire Steve Wynn debuted last month after a $1.63 billion IPO.
11/15/2009 5:36 AM JEREMIAH MARQUEZ, AP Business Writer HONG KONG
Recent Articles
- China's 618 Shopping Festival Sees Flat E-Commerce Sales from Cautious Shoppers
- Amazon Prime Day to Gauge US Consumer Strain as Focus Shifts to Basics
- China Closing in but US Still Leads in Biotech Innovation
- EV Surge Likely to Cut Oil Demand by Late 2027
- Kunal Shah tapped to Lead Meta's WhatsApp
- AbbVie Bets $10.9 Billion on Apogee in Next-Generation Immunology Growth Push
- Upscale AI Valued at $2 Billion After Funding Extension
- US and Iran Conclude High-Level Talks in Switzerland
- Oil Slips After US-Iran Conclude Talks in Switzerland
- China Targets US Rare Earth and Other Firms with Export Controls
